38520-57-9
38520-57-9 結(jié)構(gòu)式
基本信息
乙酰半胱氨酸雜質(zhì)14
乙?；?L-半胱氨酸
N-乙酰-L-胱氨酸
N-乙酰基-L-半胱氨酰胺
(2R)-2-乙酰氨-3-硫丙酰胺
(R) -2-乙酰氨基-3-巰基丙酰胺
NACA
100951
acetylcysteinamide
N-ACETYL-L-CYSTINE
N-acetylcysteine amide
N-Acetyl-L-cysteinamide
N-acetyl-L-Cysteine amide
Acetylcysteine Impurity 14
(R)-2-acetaMido-3-MercaptopropanaMide
物理化學(xué)性質(zhì)
DMSO: >40mg/mL
安全數(shù)據(jù)
| 報價日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS號 | 包裝 | 價格 |
| 2026/06/05 | HY-110256 | N-乙酰-L-胱氨酸 N-Acetylcysteine amide | 38520-57-9 | 1mg | 363元 |
| 2026/06/05 | HY-110256 | N-乙酰-L-胱氨酸 N-Acetylcysteine amide | 38520-57-9 | 5mg | 800元 |
| 2026/06/05 | HY-110256 | N-乙酰-L-胱氨酸 N-Acetylcysteine amide | 38520-57-9 | 10 mg | 1200元 |
常見問題列表
| Target | Value |
|
NF-κB
() | |
|
HIF-1α
() | |
|
ROS
() |
N-Acetylcysteine amide shows no obvious effect on the viability of H9c2 cells treated with doxorubicin (DOX) at < 1 mM, but causes significant cytotoxicity at 10-20 mM. N-Acetylcysteine amide (750 μM) reduces the ROS levle and lipid peroxidation induced by DOX, and restores GSH/GSSG ratio and activities of antioxidant enzymes, such as catalase (CAT), gluthathione peroxidase (GPx), gluthathione reductase (GR). N-Acetylcysteine amide (1 mM) protects the human brain microvascular endothelial (HBMVEC) from methamphetamine (METH)- induced cell death.
N-Acetylcysteine amide has increased CNS bioavailability. N-Acetylcysteine amide (150 mg/kg, i.p.) improves cortical sparing and functional outcome, reduces oxidative stress, improves mitochondrial bioenergetics, and maintains mitochondrial glutathione content following traumatic brain injury (TBI) in rats.